Among many, angiomotin (AMOT) and Endoplasmic Reticulum Protein 29 (ERp29) are the direct targets for miR-205 in breast cancer and miR-205 binds to the 3′ UTR site of both genes [125,126]. Here, AMOT is linked to breast carcinoma.